Categoría: Geovanny Vicente

NEW YORK, Aug. 5, 2020 /PRNewswire/ — The Lupus Research Alliance (LRA) announced today that its 2020 Lupus Insight Prize will go to Jane Salmon, MD for her work in improving the health of pregnant women with lupus and antiphospholipid syndrome. The prize will be formally «presented» to Dr. Salmon during a virtual award ceremony September 25 during the Lupus 21st Century meeting.

The LRA is recognizing Dr. Salmon’s discoveries of the causes of pregnancy complications and miscarriage in patients with lupus and in another autoimmune disease, antiphospholipid syndrome (APS), that may occur in patients with lupus and is often associated with poor pregnancy outcomes.

The prize will allow Dr. Salmon to develop a tool to identify patients with high-risk pregnancies and conduct a trial to determine whether certolizumab, a drug used for rheumatoid arthritis, will reduce pregnancy complications in lupus patients with APS. Dr. Salmon is the Collette Kean Research Professor at Hospital for Special Surgery and Professor of Medicine and Professor of Medicine in Obstetrics and Gynecology and Associate Dean for Faculty Affairs at Weill Cornell College of Medicine.

The $100,000 Lupus Insight Prize recognizes a major, novel insight and/or discovery that holds the promise of advancing the understanding of lupus and has a high likelihood of improving the diagnosis and treatment of the disease.

Over the past 15 years Dr. Salmon has focused on lupus and APS and how they cause complications during pregnancy. In her early work, Dr. Salmon identified immune molecules, known as the complement, as drivers of pregnancy complications caused by APS. In mouse models of APS, the complement system is turned on by autoantibodies on the surface of the developing placenta.  This activation unleashes inflammation that harms the placenta and can lead to pregnancy loss and/or impaired fetal growth and development. In a recent study of pregnant women, Dr. Salmon showed that complement activation is a strong predictor for adverse pregnancy outcomes in patients with lupus and/or APS.

«Forty-four percent of pregnant women with APS experience pregnancy complications, including preterm delivery and miscarriage, due to inflammation in the placenta. Therapies that reduce placental inflammation appear to be a promising treatment for patients with APS and lupus at high risk for pregnancy complications,» said Dr. Salmon.

In addition to her work on complement, Dr. Salmon has studied the role of tumor necrosis factor (TNF), a potent inflammatory molecule that causes joint destruction in rheumatoid arthritis and kidney damage in lupus.  Dr. Salmon and her team found that treatment with drugs that block the action of TNF can protect pregnant mice with APS and their fetuses from harm. This work suggested that release of TNF contributes to pregnancy loss in women with APS and lupus and served as the basis for a clinical trial (IMPACT study)  to test certolizumab, a TNF blocking drug, in high risk pregnancies in women with APS and/or lupus. The Lupus Insight Prize will allow Dr. Salmon and her colleagues to extend the IMPACT trial and determine whether and how certolizumab improves pregnancy outcomes. 

In the second part of her project, Dr. Salmon and her colleagues will develop a tool to risk stratify lupus pregnancies, that is, to determine the likelihood that a pregnancy will be uncomplicated or will lead to preeclampsia or other serious problems for the mother or fetus.  She and her team will first apply powerful computer technologies to data from the PROMISSE study, a multicenter clinical study she led that followed over 500 pregnant patients with lupus and/or APS. They hope to identify patterns of clinical features and biomarkers present at the very beginning of pregnancy that predict increased risk for complications.  She will then test her prediction algorithm with extensive data from 1,000 lupus pregnancies followed by collaborators from Europe and North America.  Once validated in this diverse patient population, her team will develop an online tool to assist physicians and patients in clinical decision making and counseling lupus patients.

«Using this tool, doctors will identify women with lupus whose pregnancies are high-risk and require increased monitoring and, when indicated, additional treatment to protect the health of mother and fetus,» said Dr. Salmon. «And, they can reassure women who are at low risk for complications.»

«Dr. Salmon has found critical links between lupus and antiphospholipid syndrome with pregnancy complications and fetal loss,» said Kenneth M. Farber, President and CEO, Lupus Research Alliance. «We are excited to fund her new work which has enormous potential to prevent pregnancy complications, such as preeclampsia, placental insufficiency, and fetal loss, using certolizumab, an FDA approved drug commonly used to treat rheumatoid arthritis.»

About Lupus

Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. More than 90% of people with lupus are women; lupus most often strikes during the childbearing years of 15-45. African Americans, Latin Americans, Asians and Native Americans are at two to three times greater risk than Caucasians. In lupus, the immune system, which is designed to protect against infection, creates antibodies that can attack any part of the body including the kidneys, brain, heart, lungs, blood, skin, and joints.

About the Lupus Research Alliance

The Lupus Research Alliance aims to transform treatment while advancing toward a cure by funding the most innovative lupus research in the world. The organization’s stringent peer review grant process fosters diverse scientific talent who are driving discovery toward better diagnostics, improved treatments and ultimately a cure for lupus. Because the Lupus Research Alliance’s Board of Directors fund all administrative and fundraising costs, 100% of all donations goes to support lupus research programs.

View original content to download multimedia:http://www.prnewswire.com/news-releases/the-lupus-research-alliance-announces-2020-lupus-insight-prize-recipient-301106247.html

SOURCE Lupus Research Alliance

LAVALLETTE, N.J., Aug. 5, 2020 /PRNewswire/ — NYNJA, the security-first, all-in-one communications platform for all your mission critical communications, announced today that it will host a webinar at 2 p.m. EDT on Thursday, August 13, to discuss the challenges and evolving best practices for university (and school) educators, administrators, and students to maintain «Education Continuity» while being remote.

Distinguished technology strategist, Shelly Palmer of the Palmer Group, will host / moderate a discussion about the future of virtual learning with some of the brightest leaders in technology and education including Casey Borman, Professor, UCLA Anderson School of Business, Dr. Ai Addyson-Zhang, Education Without Walls, and JR Guerrieri, co-founder and CEO, NYNJA. 

«There’s a lot to be uncertain about right now, yet in today’s digital age you can be certain that educators will chart new and productive paths forward for virtual learning,» said Palmer. «I’m looking forward to facilitating a vibrant discussion with some of the brightest minds in education and technology, in order to super-charge these discussions and drive best practices for virtual learning.»

The webinar discussion will focus on the pitfalls and emerging best practices, technology, features that remote educators will rely on, and in some cases adapt, to foster «Education Continuity.»

«More will be done in the next few months to reshape and advance what’s expected from the functionality and technology that’s driving critical communications in education, then any other moment in time,» said JR Guerrieri, Co-Founder and CEO, NYNJA Group. «It our passion to develop the backbone for high-level communications continuity that educators, administrators and students can rely upon during this critical moment. But like any great technology, we also want to build the foundational thinking for how best to utilize this technology in an educational setting.»

NYNJA’s passion to develop safe, secure, flexible, and reliable communications for educators and students to connect, anywhere at any time and across a variety of Internet connections – and this webinar aims to assist educators as they plan to drive curriculums this fall.

Visit www.NYNJA.work to learn more about our advanced communications offering.

About NYNJA
NYNJA is the fastest way to collaborate and communicate in one safe and secure platform, anyplace anytime. NYNJA is an all-in-one communication platform for webinars, live stream broadcasts, group messaging with automatic translations and transcription all in one safe secure platform.

NYNJA is currently available for global commercial use and can be downloaded from the company website NYNJA.work and the Samsung Galaxy store, Google Play Store and Apple App Store.

NYNJA lets users make voice and video calls to any communication device, schedule and run conference calls with screen sharing, and also share notes and files. The NYNJA platform features secure encryption of cloud data storage for saving messages, images and files.

Media Contact:
Gary Yentin
244781@email4pr.com  
416-464-2223

https://nynja.work

View original content to download multimedia:http://www.prnewswire.com/news-releases/nynja-to-host-webinar-on-august-13-2020-with-technology-and-education-leaders-to-discuss-how-to-win-with-remote-university-learning-301106534.html

SOURCE NYNJA

PARAMUS, N.J., Aug. 5, 2020 /PRNewswire/ — Savvas Learning Company is proud to announce that it is one of only two K-12 learning solutions providers selected by the Virginia Department of Education’s (VDOE) textbook review committee to deliver the complete middle school science curriculum with its Virginia Elevate Science program.

All of Savvas Learning Company’s science submissions to the VDOE, including biology and chemistry programs for high school students, passed state review and have been placed on a list of textbooks submitted to the Virginia Board of Education for final approval. The board is scheduled to take action next month.

As part of its submission, Savvas developed Virginia-specific, 2021 copyright programs that are fully aligned to the Virginia 2018 Science Standards of Learning and the Virginia Curriculum Framework. The Savvas science programs that the VDOE committee selected include:

• Virginia Elevate Science™ focuses on analysis, critical thinking, and designing solutions as students explore real-world topics and everyday phenomena.
• Virginia Miller & Levine Biology™, based on the nation’s best-selling high school biology program, immerses high school students in biological inquiry where they interact with natural phenomena through problem-based learning, scientific reasoning, and case studies.
• Virginia Experience Chemistry™, a brand new innovative approach to teaching chemistry, gets high school students to investigate real, compelling phenomena and experience how chemistry relates to their everyday lives.

«We greatly value our strong partnership with Virginia school districts and made a significant investment to create customized science programs to support every learner in Virginia,» said Ros Kane, Savvas Learning Company’s vice president of product management and marketing for science and humanities. «We are thrilled that Virginia education officials recognize the high-quality of our curricula. Our science programs provide personalized opportunities for open-ended exploration and real-world learning to prepare students for college, career, and beyond.»

ABOUT SAVVAS LEARNING COMPANY

At Savvas, we believe learning should inspire. By combining new ideas, new ways of thinking, and new ways of interacting, we design next-generation learning solutions that help prepare students to become global citizens in a more interconnected, digital world. To learn more, visit www.Savvas.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/savvas-learning-company-announces-all-of-its-science-submissions-were-approved-by-virginia-education-committee-and-now-await-final-board-approval-301106662.html

SOURCE Savvas Learning Company

PROVIDENCIALES, Turks & Caicos, Aug. 5, 2020 /PRNewswire/ — As interCaribbean Airways launched its service between Barbados and the Eastern Caribbean on August 4th, 2020, regional Tourism Ministers and stakeholders welcome the Airlines’ expansion in these new markets, citing it as necessary for regional integration.

Grenada’s Minister of Tourism, Honourable Clarice Modeste, in commenting on the decision to partner with the airline, states «Regional transport has always been the backbone of our integration movement. The Chairman of interCaribbean has seen the potential in Grenada, at a time when we were all concerned about the future of air travel in the region. Our new transport partner will help connect more people to jobs, access opportunities for students,
and bring businesses to Grenada. Our citizens, visitors and potential investors, alike, can plan for an uncertain future, with a little more confidence.»

The Minister of Tourism in Dominica, Honourable Denise Charles, was also very welcoming of the services of the carrier to that country. «The demographic of tourism is changing, and we must develop and diversify in tandem. We need to partner closely with the private sector to harness our regional integration thrust. Dominica is determined to continue attracting more visitors, and the improvement in airlift options by bringing on board the expertise and market share of interCaribbean Airways, is a significant component of our new strategic plan to
achieve this.»

interCaribbean plans to commence flights to and from Dominica on August 11th. The airline will announce its plans for its service to St. Vincent & the Grenadines once regulatory approvals have been received.

Meanwhile, from further North, the Chairman of the British Virgin Island’s Airport Authority, Mr, Bevis Sylvester, has praised the reliability and safety record of the airline, as well as its Founder and Chairman, Lyndon Gardiner, referring to him as «a visionary,» who is taking «a bold risk, and, in the process, [providing] a much-needed service for an area of the region that will desperately need it in the coming months.»

The airline counts the BVI as one of its many existing serviced cities across the North and West of the Caribbean.

Mr. Gardiner, a native of the Turks and Caicos, which is also the home-base of interCaribbean Airways, was also the recipient of much acclaim from the Premiere of that Island, Honourable Sharlene Cartwright-Robinson. She cites that TCI is «proud to be the birthplace of an entrepreneur such as Lyndon» and that the Chairman is an «example to young entrepreneurs of colour all over the region that the possible is only limited by your vision and ability to
embrace change and opportunities.»

The flight schedules between Barbados, Grenada, St. Lucia and Dominica, have already been posted on the Airline’s website, and can easily be accessed.

Visit www.interCaribbean.com to book a flight with us and, learn more about the company and its operations.

About interCaribbean
interCaribbean operates ERJ145 50 seat jets, EMB 120 30 seat Turbo Prop and 19 seat Twin Otter aircraft, connecting the Turks & Caicos Islands, Antigua, the British Virgin Islands, Puerto Rico, the Dominican Republic, Cuba, Haiti, Jamaica, the Bahamas, Dominica, St Lucia and St. Maarten. Domestic flights are operated in the Turks & Caicos Islands, as well as in Jamaica between Kingston and Montego Bay.

Media Contact:
Trevor Sadler
649-443-3102
244768@email4pr.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/regional-tourism-leaders-praise-intercaribbean-301106453.html

SOURCE interCaribbean Airways

RESTON, Va., Aug. 5, 2020 /PRNewswire/ — MeSpoke, an emerging social media platform poised to disrupt the retail advertisement industry, today announces that it has received an official patent from the United States Patent and Trademark Office that protects the core technology for its revolutionary platform.

Today, the United States Patent and Trademark Office validated the transformative power of MeSpoke’s unique platform to put everyday users in the driver’s seat and empower them to create their own commercial marketplace using their own created content.

MeSpoke’s now exclusively protected platform allows users to create their own content with embedded hashtags and share them with other users on the platform while MeSpoke’s backend algorithm assigns points to content owners depending on the type of interaction other users have with the embedded hashtags.  The accrued points can then be converted to all types of brand/retailer specific promotions, discounts, etc., for the content creators.  MeSpoke empowers everyday users to be rewarded for the content they create and share while serving as free influencers for their favorite brands and retailers. 

«The timing of the validation bestowed upon MeSpoke by the USPTO aligns perfectly with the emerging user privacy focused web 3.0.,» says MeSpoke’s CEO and founder, Sid K. Hasan.  Web 3.0 strips advertisers of their fundamental tool, the ability to track users’ online footprint to serve them with targeted content and advertisements. Apple’s recently announced iOS 14.0 puts users in charge of which applications can track their online activity.  A feature estimated to disrupt the multi billion-dollar advertisement industry, sending advertisers scrambling to find new ways of reaching their audience.  

MeSpoke is well positioned to fill the gap for retailers and brands and provide them with a completely new avenue to reach users far beyond what they can reach now using limited social influencers and online advertisements. «If you think about it, MeSpoke prides itself in making available a platform that puts users first and allows them to reap the benefit of their own created content. However, at the same time, MeSpoke allows brands and retailers to reach and develop a loyal base of customers more effectively through everyday users championing their products and brand with no capital investment. In other words, MeSpoke is presenting both sides with a win-win solution,» says Sid.

Finally, Facebook, Instagram and the giants of the social media world are now put on notice. MeSpoke is here to disrupt their retail and advertisement business model and today’s USPTO validation is just the beginning. MeSpoke is pursuing an aggressive policy in protecting its intellectual property and creating a strong IP portfolio that aligns perfectly with its core technology and long-term growth plan.

To learn more contact
Sid K. Hasan
4153770693
244792@email4pr.com 
mespoke.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/ahead-of-apples-ios-14-release-mespoke-secures-a-patent-for-the-future-of-consumer-marketing-301106656.html

SOURCE MeSpoke

MACOMB COUNTY, Mich., Aug. 5, 2020 /PRNewswire/ — New to the USA is a disinfection system to help mitigate the spread of germs from Viral Defense, a brand of products from Integrated Operations LLC.  These full disinfection systems provide a fine mist of an anti-viral/anti-bacterial solution to destroy or inactivate germs on people, their belongings and surfaces.  Depending on the application, the protective coating from the mist provides germ-fighting benefits in approximately 15 seconds and provides protection for up to 24-hours. 

«The world is at a critical point in the fight against germs such as SARS-CoV-2. We are dedicated to help mitigate the spread of germs and new infections. Our goal is to provide a cleaner, less germ-ridden environment that minimizes the fear of entering various venues,» says Nick Jaksa, founder and president of Integrated Operations. «A spray mist is the most effective way to surround the largest number of exposed surfaces including skin, clothing, shoes and accessories, and surfaces in general.»

Thousands of full disinfection fine mist systems are currently in use in Viet Nam, a country of 100 million people, with less than 652 cases of COVID-19 and 6 fatalities.  Similar concepts are being used in India, Hong Kong, Japan, France, Germany, Israel, and other countries.

Viral Defense disinfecting units have several applications, one of which is a line of walk-through chambers that uses several types of solutions, including highly diluted colloidal silver, HOCl, or others that are dispersed in a fine mist. The walk-through systems automatically detect a person’s presence, applies the mist, and leaves no residual wetness.

Viral Defense also offer portable disinfecting units that destroy or inactivate viruses and bacteria on surfaces, including whole rooms.  All solutions used in Viral Defense disinfection systems have been shown to be effective anti-viral and bacteria killing remedies against Salmonella, Staphylococcus, Listeria, Escherichia coli, Shigella flexneri and Klebsiella pneumoniae. 

«Misting booths and walkways are highly beneficial where there are high concentrations of people moving in and out of areas such as airports, schools, factories, meatpacking plants, retail stores, sports and concert venues, mass transit and other high traffic areas.  They are most useful in situations where people should not bring germs into their environment,» comments Dr. Nguyen Viet Nhung, Director, National Lung Hospital, Hanoi.

Industry leaders recognize the need for disinfection according to a recent survey conducted by Multimedia Plus among executives in the hospitality and retail industries.  Nearly 90% of respondents cited increased spending for daily cleaning as one of the biggest changes they will implement as a result of the current pandemic. Viral Defense disinfection systems are expected to provide significant cost savings in commercial cleaning.

In addition to the disinfection booths and portable misters to disinfect entire rooms, Viral Defense offers PPE products such as four-layer masks with inner layers of colloidal silver to inactivate germs, FDA cleared N95 masks, face shields, and a variety plexiglass separation panels for medical facilities, retail stores, offices, schools, and other venues.

ABOUT INTEGRATED OPERATIONS LLC
Integrated Operations, LLC was formed to bring a diverse and extensive set of professional resources to assist manufacturers to improve operational performance.  Recently the company has started its Health/Viral Defense line based on significant gaps in the marketplace to help in the fight against the global pandemic.

Media Contact:
Alise Kreditor
516-482-4866
244776@email4pr.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/integrated-operations-launches-viral-defense-disinfection-system-to-help-mitigate-spread-of-germs-including-bacteria-and-viruses-301106420.html

SOURCE Integrated Operations